Sign In
Buy PAR
$0.330
-0.0200 (-5.71%)
At Close: Nov 18, 2025
Paradigm Biopharmaceuticals Earnings Calls
Sep 30, 2025
| Release date | Feb 27, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Jun 30, 2025
| Release date | Aug 29, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0330 |
| Revenue estimate | - |
| Revenue actual | 35.42K |
Mar 30, 2025
| Release date | Jul 29, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Dec 31, 2024
| Release date | Apr 28, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0167 |
| Revenue estimate | - |
| Revenue actual | 16.7K |
Last 4 Quarters for Paradigm Biopharmaceuticals
Below you can see how PAR.AX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Dec 31, 2024
| Release date | Apr 28, 2025 |
| Price on release | $0.310 |
| EPS estimate | - |
| EPS actual | -$0.0167 |
| Date | Price |
|---|---|
| Apr 17, 2025 | $0.290 |
| Apr 22, 2025 | $0.275 |
| Apr 23, 2025 | $0.275 |
| Apr 24, 2025 | $0.300 |
| Apr 28, 2025 | $0.310 |
| Apr 29, 2025 | $0.295 |
| Apr 30, 2025 | $0.285 |
| May 01, 2025 | $0.315 |
| May 02, 2025 | $0.310 |
| 4 days before | 6.90% |
| 4 days after | 0% |
| On release day | -4.84% |
| Change in period | 6.90% |
Mar 30, 2025
| Release date | Jul 29, 2025 |
| Price on release | $0.400 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 23, 2025 | $0.430 |
| Jul 24, 2025 | $0.430 |
| Jul 25, 2025 | $0.430 |
| Jul 28, 2025 | $0.400 |
| Jul 29, 2025 | $0.400 |
| Jul 30, 2025 | $0.385 |
| Jul 31, 2025 | $0.355 |
| Aug 01, 2025 | $0.345 |
| Aug 04, 2025 | $0.345 |
| 4 days before | -6.98% |
| 4 days after | -13.75% |
| On release day | -3.75% |
| Change in period | -19.77% |
Jun 30, 2025
| Release date | Aug 29, 2025 |
| Price on release | $0.295 |
| EPS estimate | - |
| EPS actual | -$0.0330 |
| Date | Price |
|---|---|
| Aug 25, 2025 | $0.295 |
| Aug 26, 2025 | $0.290 |
| Aug 27, 2025 | $0.290 |
| Aug 28, 2025 | $0.285 |
| Aug 29, 2025 | $0.295 |
| Sep 01, 2025 | $0.280 |
| Sep 02, 2025 | $0.270 |
| Sep 03, 2025 | $0.255 |
| Sep 04, 2025 | $0.265 |
| 4 days before | 0% |
| 4 days after | -10.17% |
| On release day | -5.08% |
| Change in period | -10.17% |
Sep 30, 2025
| Release date | Feb 27, 2025 |
| Price on release | $0.540 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Feb 21, 2025 | $0.615 |
| Feb 24, 2025 | $0.600 |
| Feb 25, 2025 | $0.575 |
| Feb 26, 2025 | $0.545 |
| Feb 27, 2025 | $0.540 |
| Feb 28, 2025 | $0.490 |
| Mar 03, 2025 | $0.495 |
| Mar 04, 2025 | $0.470 |
| Mar 05, 2025 | $0.460 |
| 4 days before | -12.20% |
| 4 days after | -14.81% |
| On release day | -9.26% |
| Change in period | -25.20% |
Paradigm Biopharmaceuticals Earnings History
Earnings Calendar
FAQ
When is the earnings report for PAR.AX?
Paradigm Biopharmaceuticals Limited (PAR.AX) has scheduled its earnings report for Feb 26, 2026 before the markets open.
What is the PAR.AX price-to-earnings (P/E) ratio?
PAR.AX P/E ratio as of Nov 18, 2025 (TTM) is -6.85.
What is the PAR.AX EPS forecast?
The forecasted EPS (Earnings Per Share) for Paradigm Biopharmaceuticals Limited (PAR.AX) for the first fiscal quarter 2025 is $.
What are Paradigm Biopharmaceuticals Limited's retained earnings?
On its balance sheet, Paradigm Biopharmaceuticals Limited reported retained earnings of $0 for the latest quarter ending Sep 30, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
